Mazelsky Jonathan Jay sold 331 shares of IDEXX LABORATORIES INC DE at $711.95 for −$236k on Nov 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Executive Chair of the Board
Executive Chair of the Board
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$235,654.62Shares × reported price
Shares traded
331Common Stock
Price per share
$711.95Reported price. Read footnotes for ranges.
% of reported position traded
0.39%This security and ownership context
Holdings after
83,803.302Direct
Trade date
Nov 4, 2026Sell
Filed
Nov 5, 2026, 5:01 PM ET1-day reporting delay
Accession
0000874716-26-000144Code S · Transaction 393714
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 84,134.302 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Sell1,945$698.26−$1,358,120.56Trade 393702
Nov 4, 2026Sell4,075$699.33−$2,849,760.79Trade 393703
Nov 4, 2026Sell1,667$700.33−$1,167,441.78Trade 393704
Nov 4, 2026Sell4,540$701.36−$3,184,158.06Trade 393705
Nov 4, 2026Sell2,136$702.21−$1,499,922.06Trade 393706
Nov 4, 2026Sell3,950$703.45−$2,778,623.55Trade 393707
Nov 4, 2026Sell240$705.59−$169,341.60Trade 393708
Nov 4, 2026Sell840$707.00−$593,880Trade 393709
Nov 4, 2026Sell1,840$707.84−$1,302,433.88Trade 393710
Nov 4, 2026Sell1,300$709.00−$921,702.47Trade 393711
Nov 4, 2026Sell1,501$710.12−$1,065,891.17Trade 393712
Nov 4, 2026Sell775$711.31−$551,264.09Trade 393713
Nov 4, 2026Option exercise25,140$178.26$4,481,456.40Trade 393701
Nov 4, 2026Option exercise25,140——Trade 393715
15 transaction rows in this filing. Joint filers share the same rows.

IDXX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IDXX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.4%1w ago 0%1d ago 0%
Returns since7d +24%30d90d180d1y

Footnotes in full

F1: Represents the weighted average price of the shares sold ranging from a low of $697.80 to a high of $698.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F2: Represents the weighted average price of the shares sold ranging from a low of $698.92 to a high of $699.89 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F3: Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.80 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F4: Represents the weighted average price of the shares sold ranging from a low of $701.005 to a high of $701.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F5: Represents the weighted average price of the shares sold ranging from a low of $702.00 to a high of $702.81 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F6: Represents the weighted average price of the shares sold ranging from a low of $703.04 to a high of $703.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F7: Represents the weighted average price of the shares sold ranging from a low of $706.60 to a high of $707.16 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F8: Represents the weighted average price of the shares sold ranging from a low of $707.645 to a high of $708.59 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F9: Represents the weighted average price of the shares sold ranging from a low of $708.65 to a high of $709.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F10: Represents the weighted average price of the shares sold ranging from a low of $709.815 to a high of $710.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F11: Represents the weighted average price of the shares sold ranging from a low of $710.82 to a high of $711.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F12: Represents the weighted average price of the shares sold ranging from a low of $711.845 to a high of $712.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F13: Grant of option to buy shares of Issuer common stock that vested in five annual installments beginning February 14, 2019. F14: Not applicable.